Metraipolis › archive › dc_0e1820cae6fa
Efficacy and safety of AAV RPGR gene therapy in X-linked retinitis pigmentosa: a systematic review and meta-analysis — Europe PMC PMID:42576225
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42576225
- DOI
- 10.1186/s12967-[numero omesso]-7
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-16T22:13:22.996Z
- SHA-256 of the archived text
dee9a802d5758186c72a3b239bbe84b6ffbff83904e5ad12d60dd4e8f856f856- Stable URL of this page
https://metraipolis.com/documento/dc_0e1820cae6fa
How to cite
Efficacy and safety of AAV RPGR gene therapy in X-linked retinitis pigmentosa: a systematic review and meta-analysis — Europe PMC PMID:42576225 — Europe PMC (en), https://europepmc.org/article/MED/42576225 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0e1820cae6fa (Metraipolis archive dc_0e1820cae6fa, sha256 dee9a802d5758186c72a3b239bbe84b6ffbff83904e5ad12d60dd4e8f856f856)
BibTeX
@misc{dc0e1820cae6fa,
title = {Efficacy and safety of AAV RPGR gene therapy in X-linked retinitis pigmentosa: a systematic review and meta-analysis — Europe PMC PMID:42576225},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42576225},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0e1820cae6fa; sha256 dee9a802d5758186c72a3b239bbe84b6ffbff83904e5ad12d60dd4e8f856f856},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42576225. Agents can read the archived copy with the MCP tool read_document.